by Richard Daverman, PhD
December 5, 2013 -- Helsinn Group, a Swiss pharma that specializes in supportive cancer care, has opened a China representative office in Beijing. The company in-licenses products (drugs, medical devices and nutritional supplements), which it develops until they are approved, and then out-licenses the products to partners for distribution and sales. Helsinn hinted that the China office will look for new products, saying it hopes to form alliances with China’s scientific community. More details....
Help employers find you! Check out all the jobs and post your resume.
